These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29097554)

  • 1. Restless Legs Syndrome: clinical features, diagnosis and a practical approach to management.
    Wijemanne S; Ondo W
    Pract Neurol; 2017 Dec; 17(6):444-452. PubMed ID: 29097554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless Legs Syndrome: Contemporary Diagnosis and Treatment.
    Gossard TR; Trotti LM; Videnovic A; St Louis EK
    Neurotherapeutics; 2021 Jan; 18(1):140-155. PubMed ID: 33880737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome in the older adult: diagnosis and management.
    Milligan SA; Chesson AL
    Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating Severe Refractory and Augmented Restless Legs Syndrome.
    Winkelman JW
    Chest; 2022 Sep; 162(3):693-700. PubMed ID: 35609673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. French consensus: Augmentation syndrome in restless legs syndrome.
    Leu-Semenescu S; Petiau C; Charley Monaca C; Dauvilliers Y
    Rev Neurol (Paris); 2018; 174(7-8):532-539. PubMed ID: 30055794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
    Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
    Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
    Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
    Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome-current therapies and management of augmentation.
    Trenkwalder C; Winkelmann J; Inoue Y; Paulus W
    Nat Rev Neurol; 2015 Aug; 11(8):434-45. PubMed ID: 26215616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin enacarbil in restless legs syndrome.
    Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
    Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition, diagnosis, and treatment of restless legs syndrome.
    Smith JE; Tolson JM
    J Am Acad Nurse Pract; 2008 Aug; 20(8):396-401. PubMed ID: 18786013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Restless legs syndrome. Definition, cause and treatment].
    Jennum PJ
    Ugeskr Laeger; 2007 Sep; 169(38):3187-90. PubMed ID: 17910827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless Legs Syndrome and Sleep-Related Movement Disorders.
    Trotti LM
    Continuum (Minneap Minn); 2017 Aug; 23(4, Sleep Neurology):1005-1016. PubMed ID: 28777173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome. How to provide symptom relief with drug and nondrug therapies.
    Paulson GW
    Geriatrics; 2000 Apr; 55(4):35-8, 43-4, 47-8. PubMed ID: 10771701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Winkelman JW; Armstrong MJ; Allen RP; Chaudhuri KR; Ondo W; Trenkwalder C; Zee PC; Gronseth GS; Gloss D; Zesiewicz T
    Neurology; 2016 Dec; 87(24):2585-2593. PubMed ID: 27856776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.